 Christopher Butt
Concepts (165)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Nicotinic | 12 | 2015 | 343 | 1.400 |
Why?
| | Behavior, Animal | 3 | 2017 | 513 | 0.780 |
Why?
| | Synaptosomes | 4 | 2009 | 32 | 0.780 |
Why?
| | Docosahexaenoic Acids | 4 | 2021 | 85 | 0.660 |
Why?
| | Fatty Acids, Monounsaturated | 1 | 2017 | 54 | 0.540 |
Why?
| | Anti-Anxiety Agents | 1 | 2017 | 43 | 0.540 |
Why?
| | Polymorphism, Genetic | 4 | 2005 | 619 | 0.520 |
Why?
| | Neuroprotective Agents | 1 | 2017 | 142 | 0.500 |
Why?
| | Thalamus | 3 | 2009 | 115 | 0.490 |
Why?
| | Ethanol | 4 | 2005 | 627 | 0.490 |
Why?
| | Food-Drug Interactions | 1 | 2015 | 12 | 0.480 |
Why?
| | Fatty Acids | 2 | 2017 | 446 | 0.470 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2015 | 54 | 0.470 |
Why?
| | Growth and Development | 1 | 2014 | 9 | 0.450 |
Why?
| | Dietary Fats, Unsaturated | 1 | 2014 | 24 | 0.440 |
Why?
| | Food | 1 | 2015 | 160 | 0.430 |
Why?
| | Hippocampus | 2 | 2017 | 937 | 0.410 |
Why?
| | Body Composition | 1 | 2017 | 704 | 0.410 |
Why?
| | Anxiety | 2 | 2017 | 1078 | 0.360 |
Why?
| | Nicotine | 6 | 2015 | 339 | 0.350 |
Why?
| | Protein Subunits | 4 | 2009 | 228 | 0.350 |
Why?
| | Acetylcholine | 3 | 2009 | 204 | 0.340 |
Why?
| | Neurons | 1 | 2017 | 1611 | 0.290 |
Why?
| | Superior Colliculi | 3 | 2006 | 44 | 0.290 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2008 | 10 | 0.280 |
Why?
| | Nicotinic Antagonists | 1 | 2008 | 36 | 0.280 |
Why?
| | Arachidonic Acids | 1 | 2008 | 52 | 0.270 |
Why?
| | Central Nervous System Depressants | 2 | 2005 | 89 | 0.260 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2009 | 195 | 0.260 |
Why?
| | Brain | 5 | 2016 | 2857 | 0.240 |
Why?
| | Ganglionic Stimulants | 1 | 2005 | 15 | 0.230 |
Why?
| | Depression | 1 | 2014 | 1490 | 0.220 |
Why?
| | Animals | 19 | 2021 | 37328 | 0.200 |
Why?
| | Serum Albumin, Bovine | 1 | 2002 | 61 | 0.190 |
Why?
| | Dose-Response Relationship, Drug | 6 | 2017 | 2047 | 0.190 |
Why?
| | Receptors, Serotonin | 1 | 2002 | 34 | 0.180 |
Why?
| | Mice, Inbred C57BL | 8 | 2015 | 5866 | 0.180 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2003 | 181 | 0.170 |
Why?
| | Rats, Sprague-Dawley | 2 | 2017 | 2511 | 0.170 |
Why?
| | Nicotinic Agonists | 3 | 2015 | 136 | 0.160 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2021 | 142 | 0.160 |
Why?
| | Brain Mapping | 2 | 2006 | 532 | 0.160 |
Why?
| | Alcoholism | 2 | 2003 | 823 | 0.160 |
Why?
| | Maze Learning | 1 | 2017 | 103 | 0.140 |
Why?
| | Arachidonic Acid | 2 | 2011 | 107 | 0.130 |
Why?
| | Exploratory Behavior | 1 | 2017 | 89 | 0.130 |
Why?
| | Cell Hypoxia | 1 | 2017 | 232 | 0.130 |
Why?
| | Locomotion | 1 | 2017 | 106 | 0.130 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 416 | 0.120 |
Why?
| | Substance-Related Disorders | 1 | 2005 | 1100 | 0.120 |
Why?
| | Glutamic Acid | 1 | 2017 | 256 | 0.120 |
Why?
| | Mice | 9 | 2009 | 17969 | 0.120 |
Why?
| | Disease Models, Animal | 3 | 2017 | 4414 | 0.110 |
Why?
| | Varenicline | 1 | 2015 | 28 | 0.110 |
Why?
| | Retina | 3 | 2011 | 314 | 0.110 |
Why?
| | Mice, Inbred BALB C | 1 | 2017 | 1261 | 0.110 |
Why?
| | Weight Gain | 1 | 2017 | 536 | 0.100 |
Why?
| | Mice, Inbred AKR | 2 | 2003 | 37 | 0.100 |
Why?
| | Bone Density | 1 | 2017 | 496 | 0.100 |
Why?
| | Mice, Inbred A | 2 | 2003 | 50 | 0.100 |
Why?
| | Brain-Derived Neurotrophic Factor | 1 | 2014 | 142 | 0.100 |
Why?
| | Organ Size | 1 | 2014 | 476 | 0.100 |
Why?
| | Melatonin | 1 | 2014 | 163 | 0.100 |
Why?
| | Male | 11 | 2021 | 70140 | 0.100 |
Why?
| | Mice, Inbred C3H | 2 | 2003 | 255 | 0.100 |
Why?
| | Adiposity | 1 | 2017 | 520 | 0.100 |
Why?
| | Serotonin | 1 | 2014 | 289 | 0.090 |
Why?
| | Species Specificity | 2 | 2003 | 573 | 0.090 |
Why?
| | Rats | 3 | 2021 | 5556 | 0.090 |
Why?
| | Food, Formulated | 1 | 2011 | 15 | 0.090 |
Why?
| | Sex Factors | 1 | 2017 | 2055 | 0.090 |
Why?
| | Sus scrofa | 1 | 2011 | 64 | 0.090 |
Why?
| | Testosterone | 1 | 2014 | 404 | 0.080 |
Why?
| | Dietary Supplements | 1 | 2014 | 572 | 0.080 |
Why?
| | Body Weight | 1 | 2014 | 992 | 0.080 |
Why?
| | Female | 9 | 2017 | 75814 | 0.080 |
Why?
| | Cells, Cultured | 1 | 2017 | 4149 | 0.080 |
Why?
| | Corpus Striatum | 2 | 2009 | 174 | 0.080 |
Why?
| | Dietary Fats | 1 | 2011 | 303 | 0.080 |
Why?
| | Autoradiography | 2 | 2015 | 65 | 0.080 |
Why?
| | Rana pipiens | 3 | 2006 | 20 | 0.080 |
Why?
| | Polyunsaturated Alkamides | 1 | 2008 | 9 | 0.070 |
Why?
| | Cognition | 1 | 2016 | 1226 | 0.070 |
Why?
| | Gene Deletion | 1 | 2009 | 384 | 0.070 |
Why?
| | Endocannabinoids | 1 | 2008 | 68 | 0.060 |
Why?
| | Aging | 2 | 2016 | 1919 | 0.060 |
Why?
| | Time Factors | 1 | 2017 | 6951 | 0.060 |
Why?
| | Reflex, Startle | 2 | 2003 | 72 | 0.060 |
Why?
| | Mice, Knockout | 3 | 2009 | 3042 | 0.060 |
Why?
| | Visual Pathways | 1 | 2006 | 59 | 0.060 |
Why?
| | Myocardium | 1 | 2011 | 911 | 0.060 |
Why?
| | Binding Sites | 2 | 2015 | 1311 | 0.060 |
Why?
| | Cerebral Cortex | 1 | 2009 | 457 | 0.060 |
Why?
| | Drinking Behavior | 1 | 2005 | 13 | 0.060 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2006 | 227 | 0.060 |
Why?
| | Mice, Inbred Strains | 1 | 2005 | 404 | 0.050 |
Why?
| | Conotoxins | 1 | 2003 | 15 | 0.050 |
Why?
| | Receptors, Neurotransmitter | 1 | 2003 | 20 | 0.050 |
Why?
| | Gene Expression | 2 | 2021 | 1490 | 0.050 |
Why?
| | Mice, Inbred DBA | 1 | 2003 | 198 | 0.050 |
Why?
| | Rubidium Radioisotopes | 1 | 2003 | 9 | 0.050 |
Why?
| | Biomarkers | 1 | 2014 | 4180 | 0.050 |
Why?
| | Receptors, Cholinergic | 1 | 2003 | 40 | 0.050 |
Why?
| | Vision, Ocular | 1 | 2003 | 45 | 0.050 |
Why?
| | Rubidium | 1 | 2002 | 11 | 0.050 |
Why?
| | Azetidines | 1 | 2002 | 46 | 0.050 |
Why?
| | Iodocyanopindolol | 1 | 2002 | 2 | 0.050 |
Why?
| | Receptors, Serotonin, 5-HT1 | 1 | 2002 | 8 | 0.050 |
Why?
| | Receptor, Serotonin, 5-HT1B | 1 | 2002 | 6 | 0.050 |
Why?
| | 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2002 | 8 | 0.050 |
Why?
| | Acoustic Stimulation | 1 | 2003 | 324 | 0.050 |
Why?
| | Serotonin Receptor Agonists | 1 | 2002 | 26 | 0.050 |
Why?
| | Serotonin Antagonists | 1 | 2002 | 30 | 0.050 |
Why?
| | Histocytochemistry | 1 | 2002 | 80 | 0.050 |
Why?
| | Optic Nerve | 1 | 2002 | 66 | 0.050 |
Why?
| | Drug Interactions | 1 | 2003 | 404 | 0.040 |
Why?
| | Pregnancy | 1 | 2014 | 7035 | 0.040 |
Why?
| | Protein Binding | 1 | 2008 | 2233 | 0.040 |
Why?
| | Carbohydrates | 1 | 2021 | 67 | 0.040 |
Why?
| | Rats, Inbred F344 | 1 | 2021 | 265 | 0.040 |
Why?
| | Dopamine | 1 | 2003 | 304 | 0.040 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2002 | 227 | 0.040 |
Why?
| | Tobacco Use Disorder | 1 | 2002 | 237 | 0.040 |
Why?
| | Kinetics | 1 | 2003 | 1620 | 0.040 |
Why?
| | Feeding Behavior | 1 | 2005 | 679 | 0.040 |
Why?
| | Genotype | 1 | 2003 | 1854 | 0.030 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2002 | 768 | 0.030 |
Why?
| | Diet | 1 | 2021 | 1277 | 0.030 |
Why?
| | Mice, Mutant Strains | 2 | 2003 | 305 | 0.020 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2011 | 97 | 0.020 |
Why?
| | Tissue Distribution | 1 | 2011 | 325 | 0.020 |
Why?
| | Motor Activity | 2 | 2007 | 717 | 0.020 |
Why?
| | Random Allocation | 1 | 2011 | 369 | 0.020 |
Why?
| | Linear Models | 1 | 2011 | 855 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2011 | 866 | 0.020 |
Why?
| | Humans | 3 | 2016 | 141284 | 0.020 |
Why?
| | Excitatory Amino Acid Agonists | 1 | 2006 | 41 | 0.020 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2006 | 106 | 0.020 |
Why?
| | Corticosterone | 1 | 2007 | 240 | 0.020 |
Why?
| | Retinal Ganglion Cells | 1 | 2006 | 117 | 0.010 |
Why?
| | Memory | 1 | 2007 | 263 | 0.010 |
Why?
| | Axons | 1 | 2006 | 198 | 0.010 |
Why?
| | Synaptic Transmission | 1 | 2006 | 293 | 0.010 |
Why?
| | Neuronal Plasticity | 1 | 2006 | 303 | 0.010 |
Why?
| | Gene Targeting | 1 | 2003 | 82 | 0.010 |
Why?
| | Binding, Competitive | 1 | 2003 | 193 | 0.010 |
Why?
| | Substantia Nigra | 1 | 2003 | 58 | 0.010 |
Why?
| | Cholinergic Agonists | 1 | 2003 | 7 | 0.010 |
Why?
| | Receptor, Muscarinic M1 | 1 | 2003 | 4 | 0.010 |
Why?
| | Receptor, Muscarinic M2 | 1 | 2003 | 10 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2003 | 319 | 0.010 |
Why?
| | Bungarotoxins | 1 | 2003 | 47 | 0.010 |
Why?
| | Receptors, Muscarinic | 1 | 2003 | 20 | 0.010 |
Why?
| | Cholinergic Fibers | 1 | 2003 | 20 | 0.010 |
Why?
| | Cholinergic Antagonists | 1 | 2003 | 24 | 0.010 |
Why?
| | Liver | 1 | 2011 | 1821 | 0.010 |
Why?
| | Electrophysiology | 1 | 2003 | 218 | 0.010 |
Why?
| | Neural Inhibition | 1 | 2003 | 176 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2006 | 1724 | 0.010 |
Why?
| | Patch-Clamp Techniques | 1 | 2003 | 291 | 0.010 |
Why?
| | Ligands | 1 | 2003 | 665 | 0.010 |
Why?
| | Cell Differentiation | 1 | 2006 | 1983 | 0.010 |
Why?
| | Stress, Psychological | 1 | 2007 | 1124 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2003 | 2165 | 0.010 |
Why?
| | RNA, Messenger | 1 | 2003 | 2815 | 0.010 |
Why?
|
|
Butt's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|